51
|
Walker R, Schwartz K. Utilizing Everyday Technology to Increase Workplace Efficiency. J Acad Nutr Diet 2013. [DOI: 10.1016/j.jand.2013.06.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
52
|
Liao LM, Schwartz K, Pollak M, Graubard BI, Li Z, Ruterbusch J, Rothman N, Davis F, Wacholder S, Colt J, Chow WH, Purdue MP. Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring) 2013; 21:1478-85. [PMID: 23666639 PMCID: PMC3742622 DOI: 10.1002/oby.20138] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2012] [Accepted: 10/19/2012] [Indexed: 01/20/2023]
Abstract
OBJECTIVE The incidence of renal cell carcinoma (RCC) has increased rapidly in the U.S., particularly among African Americans. Despite a well-established link between obesity and RCC, the mechanism through which obesity increases cancer risk has yet to be established. Adipokines, such as leptin and adiponectin, may link obesity and cancer, with different quantitative effects by race. DESIGN AND METHODS We evaluated the association between leptin and adiponectin concentrations and RCC risk among Caucasians (581 cases, 558 controls) and African Americans (187 cases, 359 controls) in a case-control study conducted in Detroit and Chicago. Odds ratios (ORs) and 95% confidence intervals (95%CIs) were estimated using unconditional logistic regression. RESULTS Among controls, Caucasians had higher median adiponectin than African Americans (males: 8.2 vs. 7.0 μg/ml, P = 0.001; females: 13.4 vs. 8.4 μg/ml, P < 0.0001), and lower median leptin than African Americans (males: 11.8 vs. 14.1 ng/ml, P = 0.04; females: 28.3 vs. 45.9 ng/ml, P < 0.0001). Among Caucasians, the ORs for RCC comparing the highest (Q4) to the lowest (Q1) sex-specific quartile of leptin were 3.2 (95% CI: 1.9-5.2) for males and 4.7 (95% CI: 2.6-8.6) for females. Serum leptin was not significantly associated with RCC among African American males (OR 1.5, 95% CI: 0.7-3.1) or females (OR 2.1, 95% CI: 0.8-5.5). Higher adiponectin was associated with RCC risk among African American males (Q4 vs. Q1: OR 2.3, 95% CI: 1.1-4.6) and females (OR 2.1, 95% CI: 1.2-6.7), but not significantly among Caucasian males (OR 1.6, 95% CI: 0.99-2.7) and females (OR 1.6, 95% CI: 0.9-3.1). CONCLUSION We observed an association between both leptin and adiponectin concentrations and risk of RCC, which may differ by race. Confirmation in further investigations is needed.
Collapse
|
53
|
Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD. Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. PLoS One 2013; 8:e61879. [PMID: 23637921 PMCID: PMC3639257 DOI: 10.1371/journal.pone.0061879] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2012] [Accepted: 03/18/2013] [Indexed: 11/18/2022] Open
Abstract
The long-term effect of socioeconomic status (SES) and healthcare resources availability (HCA) on breast cancer stage of presentation and mortality rates among patients in Michigan is unclear. Using data from the Michigan Department of Community Health (MDCH) between 1992 and 2009, we calculated annual proportions of late-stage diagnosis and age-adjusted breast cancer mortality rates by race and zip code in Michigan. SES and HCA were defined at the zip-code level. Joinpoint regression was used to compare the Average Annual Percent Change (AAPC) in the median zip-code level percent late stage diagnosis and mortality rate for blacks and whites and for each level of SES and HCA. Between 1992 and 2009, the proportion of late stage diagnosis increased among white women [AAPC = 1.0 (0.4, 1.6)], but was statistically unchanged among black women [AAPC = −0.5 (−1.9, 0.8)]. The breast cancer mortality rate declined among whites [AAPC = −1.3% (−1.8,−0.8)], but remained statistically unchanged among blacks [AAPC = −0.3% (−0.3, 1.0)]. In all SES and HCA area types, disparities in percent late stage between blacks and whites appeared to narrow over time, while the differences in breast cancer mortality rates between blacks and whites appeared to increase over time.
Collapse
|
54
|
Schwartz K. Phénoconversion et transduction mécanogénique du cœur de mammifère. ACTA ACUST UNITED AC 2013. [DOI: 10.4267/10608/4206] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
55
|
Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH. Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol 2013; 32:23.e9-13. [PMID: 23453468 DOI: 10.1016/j.urolonc.2012.08.011] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2012] [Revised: 08/09/2012] [Accepted: 08/13/2012] [Indexed: 11/16/2022]
Abstract
PURPOSE The Surveillance, Epidemiology, and End Results (SEER) program is an important epidemiologic research tool to study cancer. No information is available on its pathologic accuracy for renal cell carcinoma (RCC). METHODS Central pathology review was analyzed as a part of the United States Kidney Cancer Study. Cases previously identified through the Detroit SEER registry were reviewed. The sensitivity and specificity, and positive and negative predictive values were calculated for each SEER-assigned subtype, with the central review assignments used as the reference. RESULTS Of the 498 cases included in this study, 490 (98.5%) were confirmed to be RCC. The overall agreement for histology was 78.2% (κ = 0.55); however, individual cases were frequently reclassified. The sensitivity and specificity for SEER-assigned clear cell RCC were 79.1% and 88.1%, respectively, when based solely on the ICD-O-3 morphology code 8310 (n = 310), and 99.2% and 80.5% when 8312 (RCC not otherwise specified; n = 41) was also assumed to be clear cell. Although RCC not otherwise specified is frequently grouped with clear cell, only 78.1% had this histology. Assignments of papillary and chromophobe RCC had comparable sensitivities (73.5% and 72.4%, respectively) and specificities (97.5% and 97.6%). Positive predictive values for clear cell (excluding/including 8312), papillary, and chromophobe RCC were 95.5%/93.5%, 85.9%, and 65.6%, respectively. CONCLUSIONS Our findings confirm that nearly all RCC cases are correctly classified in SEER. The positive predictive value was higher for clear cell RCC than for papillary or chromophobe RCC, suggesting that pathologic confirmation may be warranted for studies of non-clear cell tumors.
Collapse
|
56
|
Schwartz K, Mercadier JJ, Lompré AM. Génétique moléculaire de l'hypertrophie cardiaque. Med Sci (Paris) 2013. [DOI: 10.4267/10608/3440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
57
|
Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Chamberlain RM, Graff JJ, Merajver SD, Schwartz K. Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008). SPRINGERPLUS 2013; 2:3. [PMID: 23420611 PMCID: PMC3568481 DOI: 10.1186/2193-1801-2-3] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 10/02/2012] [Accepted: 12/26/2012] [Indexed: 01/16/2023]
Abstract
Introduction Inflammatory breast cancer (IBC) is characterized by an apparent geographical distribution in incidence, being more common in North Africa than other parts of the world. Despite the rapid growth of immigrants to the United States from Arab nations, little is known about disease patterns among Arab Americans because a racial category is rarely considered for this group. The aim of this study was to advance our understanding of the burden of IBC in Arab ethnic populations by describing the proportion of IBC among different racial groups, including Arab Americans from the Detroit, New Jersey and California Surveillance, Epidemiology and End Results (SEER) registries. Methods We utilized a validated Arab surname algorithm to identify women of Arab descent from the SEER registries. Differences in the proportion of IBC out of all breast cancer and IBC characteristics by race and menopausal status were evaluated using chi-square tests for categorical variables, t-tests and ANOVA tests for continuous variables, and log-rank tests for survival data. We modeled the association between race and IBC among all women with breast cancer using hierarchical logistic regression models, adjusting for individual and census tract-level variables. Results Statistically significant differences in the proportion of IBC out of all breast cancers by race were evident. In a hierarchical model, adjusting for age, estrogen and progesterone receptor, human epidermal growth receptor 2, registry and census-tract level education, Arab-Americans (OR=1.5, 95% CI=1.2,1.9), Hispanics (OR=1.2, 95% CI=1.1,1.3), Non-Hispanic Blacks (OR=1.3, 95% CI=1.2, 1.4), and American Indians/Alaskans (OR=1.9, 95% CI=1.1, 3.4) had increased odds of IBC, while Asians (OR=0.6, 95% CI=0.6, 0.7) had decreased odds of IBC as compared to Non-Hispanic Whites. Conclusions IBC may be more common among certain minority groups, including Arab American women. Understanding the descriptive epidemiology of IBC by race may generate hypotheses about risk factors for this aggressive disease. Future research should focus on etiologic factors that may explain these differences.
Collapse
|
58
|
Schwartz K, Beebani G, Sedki M, Tahhan M, Ruterbusch JJ. Enhancement and validation of an Arab surname database. JOURNAL OF REGISTRY MANAGEMENT 2013; 40:176-179. [PMID: 24625771 PMCID: PMC4373615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
OBJECTIVES Arab Americans constitute a large, heterogeneous, and quickly growing subpopulation in the United States. Health statistics for this group are difficult to find because US governmental offices do not recognize Arab as separate from white. The development and validation of an Arab- and Chaldean-American name database will enhance research efforts in this population subgroup. METHODS A previously validated name database was supplemented with newly identified names gathered primarily from vital statistic records and then evaluated using a multistep process. This process included 1) review by 4 Arabic- and Chaldean-speaking reviewers, 2) ethnicity assessment by social media searches, and 3) self-report of ancestry obtained from a telephone survey. RESULTS Our Arab- and Chaldean-American name algorithm has a positive predictive value of 91 percent and a negative predictive value of 100 percent. CONCLUSIONS This enhanced name database and algorithm can be used to identify Arab Americans in health statistics data, such as cancer and hospital registries, where they are often coded as white, to determine the extent of health disparities in this population.
Collapse
|
59
|
Hofmann JN, Schwartz K, Chow WH, Ruterbusch JJ, Shuch BM, Karami S, Rothman N, Wacholder S, Graubard BI, Colt JS, Purdue MP. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control 2013; 24:167-74. [PMID: 23179659 PMCID: PMC3531044 DOI: 10.1007/s10552-012-0102-z] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2012] [Accepted: 11/07/2012] [Indexed: 02/06/2023]
Abstract
PURPOSE In the United States, renal cell carcinoma (RCC) incidence is higher among blacks than among whites. Risk of RCC is elevated among end-stage renal disease patients, although no studies have looked at differences by race in the relationship between chronic renal failure and RCC. METHODS We investigated RCC risk in relation to chronic renal failure in a population-based case-control study of blacks and whites in Chicago and Detroit. Data, including information on kidney disease, were collected from interviews with 1,217 RCC cases (361 blacks, 856 whites) and 1,235 controls (523 blacks, 712 whites). Odds ratios (OR) and 95 % confidence intervals (CI) were estimated using unconditional logistic regression. RESULTS Risk of RCC was increased in relation to chronic renal failure (OR 4.7, 95 % CI 2.2-10.1) and dialysis (OR 18.0, 95 % CI 3.6-91). The association remained after defining exposure as those who had chronic renal failure ≥10 years prior to RCC diagnosis. Chronic renal failure was more strongly associated with RCC among blacks than among whites (OR 8.7, 95 % CI 3.3-22.9 and 2.0, 0.7-5.6, respectively; p (interaction) = 0.03) and among those without a history of diabetes relative to diabetic subjects (OR 8.3, 95 % CI 3.1-22.7 and 1.9, 0.6-5.9, respectively; p (interaction) = 0.03). CONCLUSIONS These results suggest that chronic renal failure is a strong risk factor for RCC, particularly among black and non-diabetic subjects. Our findings of differences in risk estimates by race, to our knowledge the first such report, require replication.
Collapse
|
60
|
Filson CP, Miller DC, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Schwartz K. Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma. Urol Oncol 2012; 30:856-63. [PMID: 21419672 PMCID: PMC3123686 DOI: 10.1016/j.urolonc.2010.08.024] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2010] [Revised: 08/23/2010] [Accepted: 08/24/2010] [Indexed: 11/29/2022]
Abstract
OBJECTIVES We assessed the influence of tumor size and surgical approach on the use of lymphadenectomy and adrenalectomy with radical nephrectomy. METHODS We evaluated patients with renal cell carcinoma (RCC) enrolled in the U.S. Kidney Cancer Study, a case-control study in the metropolitan areas of Detroit and Chicago from 2002 to 2007. We identified patients who underwent open (ORN) or laparoscopic radical nephrectomy (LRN). We used medical records and Surveillance, Epidemiology, and End Results (SEER) data to determine the proportion of patients who underwent lymphadenectomy or adrenalectomy. Bivariate analyses were performed to evaluate associations between tumor size, surgical approach, and receipt of lymphadenectomy or adrenalectomy. RESULTS We identified 730 patients who underwent ORN (427, 58%) or LRN (303, 42%) for RCC from 2002 to 2007. Among this group, 11% and 24% underwent lymphadenectomy or adrenalectomy, respectively. Lymphadenectomy was more common among patients treated from an open surgical approach (14.1% ORN vs. 5.9% LRN, P < 0.01); this difference was most pronounced for cases with tumors between 4 and 7 cm (15.9% vs. 2.9%, P = 0.01). Patients treated with ORN were also more likely to undergo adrenalectomy, with the greatest discrepancy among cases with tumors ≤ 4 cm (21.7% vs. 11.4%, P < 0.01). CONCLUSIONS Among patients undergoing radical nephrectomy for RCC, the use of lymphadenectomy and adrenalectomy is relatively uncommon and varies by tumor size and surgical approach. With an increasing number of patients with small tumors, the diffusion of laparoscopy, and the emergence of clinical trials evaluating systemic adjuvant therapies, our findings highlight important considerations for optimizing surgical management of patients with RCC.
Collapse
|
61
|
Schwartz K, Ruterbusch JJ, Khan F. Abstract A67: Differences in the cancer burden for foreign-born versus U.S.-born Arab Americans living in metropolitan Detroit. Cancer Epidemiol Biomarkers Prev 2012. [DOI: 10.1158/1055-9965.disp12-a67] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Introduction: Metropolitan Detroit is home to one of the largest populations of Arabs outside of the Middle East. However, cancer statistics for this population group are not available because Arab-Americans (ArA) are not considered a minority group by the federal government. Because of this limitation, little is known about the cancer burden among Arab Americans; furthermore there is no information on cancer by nativity status, which can often provide important clues to environmental factors in cancer etiology.
Methods: We developed validated name lists as well as a methodology using Social Security Numbers to identify cancer cases of probable Arab ancestry by nativity status found in the Metropolitan Detroit Cancer Surveillance System database. ArA cancer cases diagnosed between the years of 1990-2009 were identified and compared to non-Hispanic white (NHW) cases using age-standardized proportional incidence ratios (PIRs) and 95% confidence intervals. PIRs were also calculated by country of origin (US-born versus foreign-born) for ArA.
Results: A total of 9,327 Arab American cases were identified (4,463 men and 4,684 women). 46% of the ArA cases were born outside the United States. Compared to NHW, ArA men had a higher proportion of multiple myeloma, leukemia, kidney, liver, and bladder cancer. While the proportion of bladder cancer remained significantly higher among ArA men regardless of nativity status, ArA immigrants had a higher proportion of multiple myeloma, kidney, liver, and stomach cancer, while US-born ArA did not. ArA women had a higher proportion of lymphoma, leukemia, breast, gallbladder, liver, stomach, and thyroid cancer compared to NHW. This pattern remained for both foreign-born and US-born ArA females, except that female ArA immigrants had a higher proportion of breast and stomach cancer while US- born females did not.
Conclusions: As expected, cancers such as liver and stomach, which can be related to infectious causes and have a relatively high incidence in developing countries, are seen proportionally higher in the foreign-born ArA than US-born ArA as compared to NHW. However, there are other patterns that deserve further investigation. An intriguing finding was foreign-born ArA women had proportionally higher breast cancer incidence while US-born ArA women did not when compared to NHW, a pattern that is opposite in other immigrant groups. We also are interested in the higher proportion of bladder cancer in ArA men regardless of nativity. The prevalence of this cancer is high in some Arab countries and is related to an infectious cause. However, the bladder cancer seen in the U.S. is of a different histological type (transitional cell), a type that is associated with the risk factor smoking. Although smoking prevalence among ArA men is uncertain, other smoking related cancers are not over-represented proportionally, which invites etiologic questions about bladder cancer risk factors in ArA men.
Citation Format: Kendra Schwartz, Julie J. Ruterbusch, Fatima Khan. Differences in the cancer burden for foreign-born versus U.S.-born Arab Americans living in metropolitan Detroit. [abstract]. In: Proceedings of the Fifth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2012 Oct 27-30; San Diego, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(10 Suppl):Abstract nr A67.
Collapse
|
62
|
Burkhart R, Ruterbusch J, Soliman A, Meza R, Hirko K, Graff J, Schwartz K. Abstract A68: Cancer incidence among Arab Americans in California, Detroit, and New Jersey SEER registries, 2000. Cancer Epidemiol Biomarkers Prev 2012. [DOI: 10.1158/1055-9965.disp12-a68] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Objective: Because Arab Americans (ArA) are not recognized as a distinct race/ethnicity group, it is difficult to determine cancer incidence in this growing population and how it may vary across different regions in the U.S. We calculated cancer incidence rates and 95% confidence intervals for the ArA populations in California, Detroit, MI, and New Jersey and compared rates in these regions to non-Hispanic, non-Arab White (NHNAW), Black, and Hispanic races/ethnicities.
Methods: Age-adjusted rates were calculated following the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) methodology. ArA numerator data (new cancers diagnosed in 2000) were obtained for each of the three sites by linking California, Detroit, and New Jersey SEER databases with an Arab surname database previously developed and validated. Numerator data for Black and Hispanic races/ethnicities were obtained using SEER*Stat frequency sessions. NHNAW numerator data were calculated by subtracting identified ArA cases from Non-Hispanic White (NHW) SEER*Stat frequencies for each age group. Population estimates (denominators) were extracted from Public-Use Microdata Samples (PUMS) from the U.S. 2000 decennial census. ArA populations were identified using a combined value of Arab/Chaldean ancestry, birthplace in an Arab League country, or Arabic/Syriac language spoken at home, in addition; those reporting Armenian ancestry were excluded from ArA population estimates. NHNAW denominators were calculated by taking the difference between NHW and ArA estimates for each age group. Rates and 95% confidence intervals were gender specific and limited to ages 20-74 years for all cancer sites combined and for any cancer site that had at least ArA 10 cases in 2 of the 3 regions.
Results: ArA males had similar rates across the 3 geographic areas and generally similar to NHNAW. ArA males all sites combined and lung incidence rates were generally lower than Black and higher than Hispanic rates. Prostate cancer incidence was significantly lower among ArA than Black incidence in all three geographic regions. ArA male bladder incidence was higher than Hispanic and/or Black in the three regions. ArA females also had similar rates across the 3 geographic areas and rates similar to NHNAW. In New Jersey, female all sites combined incidence was significantly higher among ArA than New Jersey Black and Hispanic rates; while in California ArA female all sites combined was higher than only Hispanic. In California, ArA female lung and breast incidence was higher than Hispanic. ArA thyroid cancer rates in California and Detroit were higher than Black rates.
Conclusion: We were able to estimate ArA cancer incidence in 3 geographic areas that together make up a large proportion of U.S. ArAs. Although ArA incidence rates in general were similar to NHNAW rates, we found significant differences between ArA and other races/ethnicities for several cancer sites including male lung, male bladder, and female breast, lung and thyroid. Due to the small ArA case numbers, the confidence intervals were large and may consequently mask true differences between this special population group and NHNAW. Our results call for the need to federally recognize ArA as a specified race/ethnicity in order to estimate cancer incidence and mortality in a method similar to other race/ethnicity groups.
Citation Format: Rachel Burkhart, Julie Ruterbusch, Amr Soliman, Rafael Meza, Kelly Hirko, John Graff, Kendra Schwartz. Cancer incidence among Arab Americans in California, Detroit, and New Jersey SEER registries, 2000. [abstract]. In: Proceedings of the Fifth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2012 Oct 27-30; San Diego, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(10 Suppl):Abstract nr A68.
Collapse
|
63
|
Noch E, Pina-Oviedo S, Perez-Liz G, Bookland M, Del Valle L, Gordon J, Khalili K, Juratli TA, Peitzsch M, Geiger K, Schackert G, Eisenhofer G, Krex D, Chaumeil MM, Woods SM, Danforth RM, Yoshihara H, Lodi A, Robinson A, Lupo JM, Pieper RO, Phillips JJ, Ronen SM, Schonberg DL, Heddleston JM, Hjelmeland AB, Rich JN, Rahim SAA, Sanzey M, Bjerkvig R, Niclou SP, Mustafa DAM, Swagemakers SMA, van der Spek PJ, Kros JM, Vartanian A, Singh SK, Zadeh G, Lim KS, Lim KJ, Orr BA, Price AC, Eberhart CG, Bar EE, Liu WM, Huang P, Nowacki A, Distelhorst C, Lathia J, Rich J, Kappes J, Gladson C, Schwartz K, Chang H, Karl Olson L. LAB-METABOLIC PATHWAYS. Neuro Oncol 2012. [DOI: 10.1093/neuonc/nos226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
64
|
Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Chamberlain R, Graff JJ, Merajver SD, Schwartz K. Abstract A61: Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit, and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008). Cancer Epidemiol Biomarkers Prev 2012. [DOI: 10.1158/1055-9965.disp12-a61] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Introduction: Inflammatory breast cancer (IBC) is characterized by an apparent geographical distribution in incidence, being more common in North Africa than other parts of the world. Despite the rapid growth of immigrants to the United States from Arab nations, because a racial category is rarely appropriated for this group, little is known about disease patterns among Arab Americans. The aim of this study was to describe the proportion of IBC among different racial groups, including Arab Americans from the Detroit, New Jersey and California Surveillance, Epidemiology and End Results (SEER) registries.
Methods: We utilized a validated Arab surname algorithm to identify women of Arab descent from the SEER registries. Differences in the proportion of IBC out of all breast cancer and IBC characteristics by race and menopausal status were evaluated using chi-square tests for categorical variables, t-tests and ANOVA tests for continuous variables, and log-rank tests for survival data. We modeled the association between race and IBC among all women with breast cancer using hierarchical logistic regression models, adjusting for individual and county-level variables.
Results: Statistically significant differences in the proportion of IBC out of all breast cancers by race were evident. In a hierarchical model, adjusting for age, estrogen and progesterone receptor, human epidermal growth receptor 2, registry and county-level socioeconomic position, Arab-Americans (OR=1.5, 95% CI=1.2,1.9), Hispanics (OR=1.2, 95% CI=1.1,1.3), Non-Hispanic Blacks (OR=1.3, 95% CI=1.2, 1.4), and American Indians/Alaskans (OR=1.9, 95% CI=1.1, 3.4) had increased odds of IBC, while Asians had decreased odds of IBC as compared to Non-Hispanic Whites (OR=0.6, 95% CI=0.6, 0.7).
Conclusions: IBC may be more common among certain minority groups, including Arab American women. Understanding the descriptive epidemiology of IBC by race may generate hypotheses about risk factors for this aggressive disease. Future research should focus on etiologic factors that may explain these differences.
Citation Format: Kelly A. Hirko, Amr S. Soliman, Mousumi Banerjee, Julie Ruterbusch, Joe B. Harford, Robert Chamberlain, Jon J. Graff, Sofia D. Merajver, Kendra Schwartz. Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit, and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008). [abstract]. In: Proceedings of the Fifth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2012 Oct 27-30; San Diego, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(10 Suppl):Abstract nr A61.
Collapse
|
65
|
Smith BF, Colburn DS, Schubert G, Schwartz K, Sonett CP. Induced magnetosphere of the Moon: 2. Experimental results from Apollo 12 and Explorer 35. ACTA ACUST UNITED AC 2012. [DOI: 10.1029/ja078i025p05437] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
66
|
Schubert G, Sonett CP, Schwartz K, Lee HJ. Induced magnetosphere of the Moon: 1. Theory. ACTA ACUST UNITED AC 2012. [DOI: 10.1029/ja078i013p02094] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
67
|
|
68
|
Karami S, Colt JS, Schwartz K, Davis FG, Ruterbusch JJ, Munuo SS, Wacholder S, Stewart PA, Graubard BI, Rothman N, Chow WH, Purdue MP. A case-control study of occupation/industry and renal cell carcinoma risk. BMC Cancer 2012; 12:344. [PMID: 22873580 PMCID: PMC3502582 DOI: 10.1186/1471-2407-12-344] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2012] [Accepted: 07/09/2012] [Indexed: 01/22/2023] Open
Abstract
Background The role of occupation in the etiology of renal cell carcinoma (RCC) is unclear. Here, we investigated associations between employment in specific occupations and industries and RCC, and its most common histologic subtype, clear cell RCC (ccRCC). Methods Between 2002 and 2007, a population-based case–control study of Caucasians and African Americans (1,217 cases; 1,235 controls) was conducted within the Detroit and Chicago metropolitan areas to investigate risk factors for RCC. As part of this study, occupational histories were ascertained through in-person interviews. We computed odds ratios (ORs) and 95% confidence intervals (CIs) relating occupation and industry to RCC risk using adjusted unconditional logistic regression models. Results Employment in the agricultural crop production industry for five years or more was associated with RCC (OR = 3.3 [95% CI = 1.0-11.5]) and ccRCC in particular (OR = 6.3 [95% CI = 1.7-23.3], P for trend with duration of employment = 0.0050). Similarly, RCC risk was elevated for employment of five years or longer in non-managerial agricultural and related occupations (ORRCC = 2.1 [95% CI = 1.0-4.5]; ORccRCC = 3.1 [95% CI = 1.4-6.8]). Employment in the dry-cleaning industry was also associated with elevated risk (ORRCC = 2.0 [95% CI = 0.9-4.4], P for trend = 0.093; ORccRCC = 3.0 [95% CI = 1.2-7.4], P for trend = 0.031). Suggestive elevated associations were observed for police/public safety workers, health care workers and technicians, and employment in the electronics, auto repair, and cleaning/janitorial services industries; protective associations were suggested for many white-collar jobs including computer science and administrative occupations as well employment in the business, legislative, and education industries. Conclusions Our findings provide support for an elevated risk of RCC in the agricultural and dry-cleaning industries and suggest that these associations may be stronger for the ccRCC subtype. Additional studies are needed to confirm these findings.
Collapse
|
69
|
Dallo FJ, Schwartz K, Ruterbusch JJ, Booza J, Williams DR. Mortality rates among Arab Americans in Michigan. J Immigr Minor Health 2012; 14:236-41. [PMID: 21318619 DOI: 10.1007/s10903-011-9441-1] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
The objectives of this study were to: (1) calculate age-specific and age-adjusted cause-specific mortality rates for Arab Americans; and (2) compare these rates with those for blacks and whites. Mortality rates were estimated using Michigan death certificate data, an Arab surname and first name list, and 2000 U.S. Census data. Age-specific rates, age-adjusted all-cause and cause-specific rates were calculated. Arab Americans (75+) had higher mortality rates than whites and blacks. Among men, all-cause and cause-specific mortality rates for Arab Americans were in the range of whites and blacks. However, Arab American men had lower mortality rates from cancer and chronic lower respiratory disease compared to both whites and blacks. Among women, Arab Americans had lower mortality rates from heart disease, cancer, stroke, and diabetes than whites and blacks. Arab Americans are growing in number. Future study should focus on designing rigorous separate analyses for this population.
Collapse
|
70
|
Simon MS, Lamerato L, Krajenta R, Booza JC, Ruterbusch JJ, Kunz S, Schwartz K. Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health system. Int J Breast Cancer 2012; 2012:453985. [PMID: 22690339 PMCID: PMC3363414 DOI: 10.1155/2012/453985] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2012] [Revised: 03/18/2012] [Accepted: 03/19/2012] [Indexed: 11/17/2022] Open
Abstract
Background. Racial differences in breast cancer survival may be in part due to variation in patterns of care. To better understand factors influencing survival disparities, we evaluated patterns of receipt of adjuvant chemotherapy among 2,234 women with invasive, nonmetastatic breast cancer treated at the Henry Ford Health System (HFHS) from 1996 through 2005. Methods. Sociodemographic and clinical information were obtained from linked datasets from the HFHS, Metropolitan Detroit Cancer Surveillance Systems, and U.S. Census. Comorbidity was measured using the Charlson comorbidity index (CCI), and economic deprivation was categorized using a neighborhood deprivation index. Results. African American (AA) women were more likely than whites to have advanced tumors with more aggressive clinical features, to have more comorbidity and to be socioeconomically deprived. While in the unadjusted model, AAs were more likely to receive chemotherapy (odds ratio (OR) 1.22, 95% confidence interval (CI) 1.02-1.46) and to have a delay in receipt of chemotherapy beyond 60 days (OR 1.68, 95% CI, 1.26-1.48), after multivariable adjustment there were no racial differences in receipt (odds ratio (OR) 1.02, 95% confidence interval (CI) 0.73-1.43), or timing of chemotherapy (OR 1.18, 95 CI, 0.8-1.74). Conclusions. Societal factors and not race appear to have an impact on treatment delay among African American women with early breast cancer.
Collapse
|
71
|
Akinyemiju TF, Soliman AS, Yassine M, Banerjee M, Schwartz K, Merajver S. Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study. Int J Equity Health 2012; 11:16. [PMID: 22436125 PMCID: PMC3414751 DOI: 10.1186/1475-9276-11-16] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2011] [Accepted: 03/21/2012] [Indexed: 12/28/2022] Open
Abstract
BACKGROUND Breast cancer screening rates have increased over time in the United States. However actual screening rates appear to be lower among black women compared with white women. PURPOSE To assess determinants of breast cancer screening among women in Michigan USA, focusing on individual and neighborhood socio-economic status and healthcare access. METHODS Data from 1163 women ages 50-74 years who participated in the 2008 Michigan Special Cancer Behavioral Risk Factor Survey were analyzed. County-level SES and healthcare access were obtained from the Area Resource File. Multilevel logistic regression models were fit using SAS Proc Glimmix to account for clustering of individual observations by county. Separate models were fit for each of the two outcomes of interest; mammography screening and clinical breast examination. For each outcome, two sequential models were fit; a model including individual level covariates and a model including county level covariates. RESULTS After adjusting for misclassification bias, overall cancer screening rates were lower than reported by survey respondents; black women had lower mammography screening rates but higher clinical breast examination rates than white women. However, after adjusting for other individual level variables, race was not a significant predictor of screening. Having health insurance or a usual healthcare provider were the most important predictors of cancer screening. DISCUSSION Access to healthcare is important to ensuring appropriate cancer screening among women in Michigan.
Collapse
|
72
|
Han SS, Yeager M, Moore LE, Wei MH, Pfeiffer R, Toure O, Purdue MP, Johansson M, Scelo G, Chung CC, Gaborieau V, Zaridze D, Schwartz K, Szeszenia-Dabrowska N, Davis F, Bencko V, Colt JS, Janout V, Matveev V, Foretova L, Mates D, Navratilova M, Boffetta P, Berg CD, Grubb RL, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Albanes D, Weinstein SJ, Virtamo J, Burdett L, Brisuda A, McKay JD, Fraumeni JF, Chatterjee N, Rosenberg PS, Rothman N, Brennan P, Chow WH, Tucker MA, Chanock SJ, Toro JR. The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet 2012; 21:1190-200. [PMID: 22113997 PMCID: PMC3277315 DOI: 10.1093/hmg/ddr551] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2011] [Revised: 11/15/2011] [Accepted: 11/18/2011] [Indexed: 12/13/2022] Open
Abstract
In follow-up of a recent genome-wide association study (GWAS) that identified a locus in chromosome 2p21 associated with risk for renal cell carcinoma (RCC), we conducted a fine mapping analysis of a 120 kb region that includes EPAS1. We genotyped 59 tagged common single-nucleotide polymorphisms (SNPs) in 2278 RCC and 3719 controls of European background and observed a novel signal for rs9679290 [P = 5.75 × 10(-8), per-allele odds ratio (OR) = 1.27, 95% confidence interval (CI): 1.17-1.39]. Imputation of common SNPs surrounding rs9679290 using HapMap 3 and 1000 Genomes data yielded two additional signals, rs4953346 (P = 4.09 × 10(-14)) and rs12617313 (P = 7.48 × 10(-12)), both highly correlated with rs9679290 (r(2) > 0.95), but interestingly not correlated with the two SNPs reported in the GWAS: rs11894252 and rs7579899 (r(2) < 0.1 with rs9679290). Genotype analysis of rs12617313 confirmed an association with RCC risk (P = 1.72 × 10(-9), per-allele OR = 1.28, 95% CI: 1.18-1.39) In conclusion, we report that chromosome 2p21 harbors a complex genetic architecture for common RCC risk variants.
Collapse
|
73
|
Peterson L, Soliman A, Ruterbusch JJ, Smith N, Schwartz K. Comparison of exposures among Arab American and non-Hispanic White female thyroid cancer cases in metropolitan Detroit. J Immigr Minor Health 2012; 13:1033-40. [PMID: 21647624 DOI: 10.1007/s10903-011-9485-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Arab American (ArA) women may be at greater risk for thyroid cancer (TC) than White women. This case-case comparison explored differences in known and proposed risk factors of TC among ArA and non-Hispanic White (NHW) female TC cases in metropolitan Detroit. Cases of invasive TC identified from a population-based registry responded to a telephone survey regarding potential TC risk factors. Thirty ArA women (response rate 52%) and 70 NHW women (67%) participated. NHW women reported significantly more prior thyroid disease (TD), family history of TD, hormone use, cumulative years of hormone use, cigarette and alcohol consumption. In adjusted logistic regression analysis, ArA women had significantly higher odds of exposure to dental x-rays (OR = 3.48, CI 1.01-12.00) and medical radiation (OR = 13.58, CI 1.49-124.04) than NHW women. Risk factors for TC may differ among ArA women and their NHW counterparts.
Collapse
|
74
|
Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg ML, Aulwurm S, Bühring HJ, Schwartz K, Haen SP, Schilbach K, Rammensee HG, Salih HR, Jung G. Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia. Leukemia 2012; 26:1228-37. [PMID: 22289926 DOI: 10.1038/leu.2011.372] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The therapeutic efficacy of humanized or chimeric second-generation antitumor antibodies is clearly established, but often limited. In recent years, defined modifications of the glycosylation pattern or the amino-acid sequence of the human immunoglobulin G1 Fc part have resulted in the development of third-generation antibodies with improved capability to recruit Fc receptor-bearing effector cells. The first antibodies of this kind, currently evaluated in early clinical trials, are directed against lymphoma-associated antigens. Fc-engineered antibodies targeting myeloid leukemia are not yet available. We here report on the generation and preclinical characterization of an Fc-optimized antibody directed to the FMS-related tyrosine kinase 3 (FLT3), an antigen expressed on the leukemic blasts of all investigated patients with acute myeloid leukemia (AML). This antibody, termed 4G8SDIEM, mediated markedly enhanced cellular cytotoxicity against FLT3-expressing cell lines as well as blasts of AML patients. FLT3 expression levels on AML cells varied between 300 and 4600 molecules/cell and, in most cases, were substantially higher than those detected on normal hematopoietic precursor cells and dendritic cells (approximately 300 molecules/cell). Antibody-mediated cytotoxicity against these normal cells was not detectable. 4G8SDIEM has been produced in pharmaceutical quality in a university-owned production unit and is currently used for the treatment of leukemia patients.
Collapse
|
75
|
Kato I, Booza J, Quarshie WO, Schwartz K. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma. JOURNAL OF REGISTRY MANAGEMENT 2012; 39:158-166. [PMID: 23493021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
PURPOSE Census tract variables have not been widely available for SEER-wide data due to several technical reasons; thus, prior studies have been conducted on a specific-community basis only or used county-level data. This study is the first to evaluate long-term chronological trends in cancer survival by selected socioeconomic variables of census tract level based on multiple SEER registry data. METHODS 177,128 breast cancer and 45,615 non-Hodgkin's lymphoma (NHL) cases diagnosed from 1973-2007 and followed through 2009 from 4 SEER registries (Detroit, Hawaii, Utah and Seattle-Puget Sound), were linked to decennial census tract data (1970-2000). Five-year relative survival was calculated using the lifetable method according to census tract poverty levels and by year of diagnosis. The Cox proportional hazard model was used to estimate hazard ratios (HR) for death in 5 years from diagnosis, adjusted for selected covariates and SEER historical stage in the limited models only. RESULTS Although the 5-year relative survival from both cancers improved similarly across poverty levels as percent per year, absolute increase per year was greater for lower poverty neighborhoods. This trend was most consistently observed for distant stage of cancer. The multivariable HR were significantly higher in the highest poverty group (greater than 20%), 1.41 and 1.33, for breast cancer and NHL respectively, than the lowest (greater than or equal to 5%). Additional adjustment for stage at diagnosis reduced the HR in the highest poverty level in breast cancer patients to 1.30, but had minimal effect on NHL. Socioeconomic disparities in overall survival were more evident in neighborhoods with higher proportions of racial minorities and in middle-aged patients than younger or older patients. CONCLUSIONS Relative survival for both types of cancer improved over last 35-year period across poverty levels, but absolute differences increased. More studies are needed to develop innovative community-level interventions.
Collapse
|